Carmell Corporation - Warrant
Carmell Corporation - Warrant
Share · US1429221112 · CTCXW (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % 7,23 % -34,07 % -70,33 % -93,49 %

Company Profile for Carmell Corporation - Warrant Share

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Company Data

Name Carmell Corporation - Warrant
Company Carmell Therapeutics Corporation
Symbol CTCXW
Website https://www.carmellrx.com
Primary Exchange XNAS NASDAQ
ISIN US1429221112
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Rajiv Sarman Shukla
Country United States of America
Currency USD
Employees 0,0 T
Address 2403 Sidney Street, 15203 Pittsburgh

ID Changes

Date From To
17.07.2023 ALPAW CTCXW

Ticker Symbols

Name Symbol
NASDAQ CTCXW

More Shares

Investors who Carmell Corporation - Warrant hold also have the following shares in their portfolio:
BARING GER.GR.TR. INC EO
BARING GER.GR.TR. INC EO Fund
BGF-US BASIC VAL.NAM.A4
BGF-US BASIC VAL.NAM.A4 Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025